DarioHealth Corp. (DRIO) Financials
DRIO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 106.5 million | 38.5 million |
2023-06-30 | 117.2 million | 38.8 million |
2023-03-31 | 108.0 million | 36.0 million |
2022-12-31 | 119.2 million | 39.2 million |
DRIO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -8.9 million | 5.2 million |
2023-06-30 | -9.8 million | 5.3 million |
2023-03-31 | -4.8 million | 4.9 million |
2022-12-31 | -8.0 million | 3.1 million |
DRIO Net Income
No data available :(
DRIO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 43.9 million | - | 923000 |
2023-06-30 | 52.6 million | 29.1 million | 1.0 million |
2023-03-31 | 43.1 million | 16.7 million | 1.0 million |
2022-12-31 | 49.4 million | 18.1 million | 1.1 million |
DRIO Shares Outstanding
DRIO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 281000 | 5.7 million | 4.1 million | 6.4 million |
2023-06-30 | 146000 | 5.2 million | 4.4 million | 6.5 million |
2023-03-31 | 74000 | 5.2 million | 4.1 million | 6.3 million |
2022-12-31 | 59000 | 4.8 million | 3.0 million | 3.9 million |
DRIO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 3.5 million | 2.9 million |
2023-06-30 | 6.2 million | 4.1 million |
2023-03-31 | 7.1 million | 3.9 million |
2022-12-31 | 6.8 million | 4.1 million |
DRIO
Price: $1.50
52 week price:
Earnings Per Share: -2.04 USD
P/E Ratio: -1
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 139000
Ebitda: -2.9 millionMarket Capitalization: 39.7 million